DIARIOFARMA | 28.09.2021 – 13:22
The “pharmacist is also a first-rate health agent”, a work prepared by the ProPatiens Institute foundation, which will be officially presented in the first half of October and whose objective is to make an in-depth analysis of the figure of the office pharmacist of pharmacy, its profile, its functions, its patient experience, its main challenges, its future and its performance.
The work has been carried out in the Community of Madrid and 519 users of the Madrid pharmacy office, 44 national and regional patient associations and 17 community pharmacists who practice their specialty both at the metropolitan level and in the rural environment have participated.
Among the most relevant results, in the chapter on synergies and complementarities between pharmacy offices and the hospital pharmacy, 86.1% of patients request that the drugs they currently have to collect in hospitals be also dispensed in pharmacy offices .
On the other hand, as to whether there are actions that can be carried out in pharmacy offices, such as collaboration in early detection to reduce the risk of suffering from diseases, in addition to nutritional advice, monitoring of healthy habits, improvement of therapeutic adherence or other aspects such as the presence of the antigen detection test service (63.4% answered affirmatively) or the availability of the vaccination service against SARS-CoV-2 (Covid-19) in said pharmacy offices (54 , 6% answered positively) also reach very relevant acceptance percentages.
The Avicena study concludes that “the pharmacist is also a first-rate health agent. In the pharmacy offices there is constant and close contact with both the patient and their family, so they can develop new functions that help reduce the pressure of the National Health System (NHS) by improving adherence to the prescribed therapy through monitoring and control of the patient’s medication.
In addition, pharmacy office users, patient associations and pharmacists themselves consider the incorporation and use of information and communication technologies (ICTs) essential to give greater continuity and longitudinality to the follow-up of patient care. At the present time, according to the reference study, only 22% of the respondents had received information from the pharmacy through the new information and communication technologies (ICTs) as a patient at home.
In this sense, the study indicates the necessary implementation and development of these new technologies “due to the advantages and benefits that they entail for the patient and the user in terms of improving their health results, comfort and quality of life, especially at times like the current ones in which chronicity and polypathologies associated with aging, frailty and dependency are the norm in our society ”.
The questions asked both to patients and to pharmacists with a pharmacy office have been prepared and validated by the scientific committee of the project. The methodology and statistical analysis are developed by the Chair of the Patient and are endorsed by the Steering Committee of the ProPatiens Institute.
Jesús Díaz, executive vice president, has indicated that “the main objective of the ProPatiens Institute is to once again add value to the associations through this study in which the opinion of patients is compared with that of one of its direct interest groups within the health sector, in this case the pharmacists of the pharmacy office, with the aim of improving the quality of care and relations with the associations and patients they represent ”.
Finally, Fernando Mugarza, secretary of the Institute, explained that “the better the patient experience, the better the perception of improvement in their health. Therefore, understanding the processes from the patient’s perspective, with a comprehensive vision, is key. To do this, knowing the patient’s experience in the different phases of the healthcare process and, in this case, specifically in their contact with the pharmacy, is the best way to measure the quality and excellence of the service provided ”.
The Madrid Official College of Pharmacists also participate in the study and entities such as the Cofares group and the Business Federation of Spanish Pharmacists (FEFE) collaborate.
The questions asked to both patients and pharmacists have been prepared and validated by the scientific committee of the project composed of the coordinator Mercedes González Gomis (pharmacist and secretary of the COFM), and the members Asunción Redín Flamarique (pharmacist and scientific advisor of the Cofares Group) , Raquel Casado Álvaro (pharmacist and member of the Rural Pharmacy of COFM) and Noelia Tejedor García (pharmacist and president of SEFAC Madrid). The methodology and statistical analysis has been carried out with the supervision and collaboration of the Chair of the Patient (formed by the ProPatiens Institute, the University of Alicante and the Miguel Hernández University).